全球生物分析检测服务市场规模、份额、趋势和成长分析报告（2026-2034年）

预计生物分析测试服务市场将从 2025 年的 51.6 亿美元成长到 2034 年的 112.7 亿美元，2026 年至 2034 年的复合年增长率为 9.07%。

随着製药和生技公司不断扩大研发活动，全球生物分析检测服务市场正经历显着成长。这些服务在药物研发过程中至关重要，因为它们能够分析生物样本，评估药物浓度、代谢和安全性。随着复杂生物製药和先进治疗方法的研发不断推进，製药公司越来越依赖专业的检测服务，以确保符合监管要求并维持药物研发的效率。

推动市场发展的关键因素之一是将检测服务外包给合约研究组织（CRO）的趋势日益增长。製药公司之所以倾向于外包，是因为这可以降低营运成本，使他们能够专注于核心研发活动。此外，全球临床试验数量的不断增加也催生了对生物分析检测的强劲需求。分析仪器的技术进步，包括质谱和层析法，也不断提高生物检体分析的准确性和速度。

随着个人化医疗和生物製药的日益普及，生物分析检测服务市场预计将进一步成长。日益严格的药品安全监管也将需要更精细的检测和验证流程。随着全球药物研发活动的扩张，新兴市场有望在未来的市场成长中发挥重要作用。分析技术的持续创新将进一步推动市场发展，并有助于提升检测能力。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球生物分析检测服务市场：依分子类型划分

• 市场分析、洞察与预测
• 低分子
• 聚合物化合物

第五章 全球生物分析检测服务市场：依检测类型划分

• 市场分析、洞察与预测
• DMPK 测试
• 生物标记检测
• 病毒检测
• 体内病毒学检测
• 体外病毒学
• 血清学检测
• 免疫抗原性试验
• 其他测试类型

第六章 全球生物分析检测服务市场：依应用划分

• 市场分析、洞察与预测
• 肿瘤学
• 神经病学
• 感染疾病
• 胃肠病学
• 循环系统
• 其他用途

第七章 全球生物分析检测服务市场：依最终用途划分

• 市场分析、洞察与预测
• 製药和生物技术公司
• 受託研究机构
• 研究和学术机构
• 其他最终用户

第八章 全球生物分析检测服务市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • BioAgilytix
  • Charles River Laboratories Inc
  • Eurofins Scientific
  • Frontage Labs
  • ICON Plc
  • Intertek Group Plc
  • Labcorp Drug Development
  • Pace Analytical Services LLC
  • SGS SociAfA（C）TAfA（C）GAfA（C）NAfA（C）Rale De Surveillance SA
  • Syneos Health
  • Thermo Fisher Scientific Inc
  • WuXi AppTec

The Bioanalytical Testing Services Market size is expected to reach USD 11.27 Billion in 2034 from USD 5.16 Billion (2025) growing at a CAGR of 9.07% during 2026-2034.

The global bioanalytical testing services market is witnessing significant growth as pharmaceutical and biotechnology companies continue to increase research and development activities. These services are essential in drug development because they analyze biological samples to evaluate drug concentration, metabolism, and safety. As the development of complex biologics and advanced therapies increases, pharmaceutical companies are relying heavily on specialized testing services to ensure compliance with regulatory requirements and maintain drug development efficiency.

One of the key drivers of the market is the rising trend of outsourcing testing services to contract research organizations. Pharmaceutical companies prefer outsourcing because it reduces operational costs and allows them to focus on core research activities. Additionally, the increasing number of clinical trials worldwide is creating strong demand for bioanalytical testing. Technological advancements in analytical instruments, including mass spectrometry and chromatography, are also improving the precision and speed of biological sample analysis.

Looking ahead, the bioanalytical testing services market is expected to grow further as personalized medicine and biologic therapies become more common. Increasing regulatory scrutiny regarding drug safety will also require more detailed testing and validation processes. Emerging markets are expected to play an important role in future expansion as pharmaceutical research activities grow globally. Continuous innovation in analytical technologies will further support market development and improve testing capabilities.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Molecule Type

• Small Molecule
• Large Molecule

By Test Type

• Dmpk Testing
• Biomarker Testing
• Virology Testing
• In-Vivo Virology Testing
• In-Vitro Virology Testing
• Serology Testing
• Immunogenicity Testing
• Other Test Types

By Application

• Oncology
• Neurology
• Infectious Diseases
• Gastroenterology
• Cardiology
• Other Applications

By End-Use

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Research & Academic Institutes
• Other End-Users

COMPANIES PROFILED

• BioAgilytix, Charles River Laboratories Inc, Eurofins Scientific, Frontage Labs, ICON Plc, Intertek Group Plc, Labcorp Drug Development, Pace Analytical Services LLC, SGS Socit Gnrale de Surveillance SA, Syneos Health, Thermo Fisher Scientific Inc, WuXi AppTec
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: BY MOLECULE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Molecule Type
• 4.2. Small Molecule Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Large Molecule Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test Type
• 5.2. Dmpk Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Biomarker Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Virology Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. In-Vivo Virology Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. In-Vitro Virology Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Serology Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Immunogenicity Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Other Test Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Gastroenterology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Research & Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other End-Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Molecule Type
  • 8.2.2 By Test Type
  • 8.2.3 By Application
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Molecule Type
  • 8.3.2 By Test Type
  • 8.3.3 By Application
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Molecule Type
  • 8.4.2 By Test Type
  • 8.4.3 By Application
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Molecule Type
  • 8.5.2 By Test Type
  • 8.5.3 By Application
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Molecule Type
  • 8.6.2 By Test Type
  • 8.6.3 By Application
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BIOANALYTICAL TESTING SERVICES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 BioAgilytix
  • 10.2.2 Charles River Laboratories Inc
  • 10.2.3 Eurofins Scientific
  • 10.2.4 Frontage Labs
  • 10.2.5 ICON Plc
  • 10.2.6 Intertek Group Plc
  • 10.2.7 Labcorp Drug Development
  • 10.2.8 Pace Analytical Services LLC
  • 10.2.9 SGS SociAfA(C)TAfA(C) GAfA(C)NAfA(C)Rale De Surveillance SA
  • 10.2.10 Syneos Health
  • 10.2.11 Thermo Fisher Scientific Inc
  • 10.2.12 WuXi AppTec